Zura Bio Limited
ZURA
$3.51
-$0.21-5.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.86% | -54.84% | -125.15% | -60.80% | -150.33% |
| Total Depreciation and Amortization | 366.67% | 1,000.00% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -80.93% | 2.25% | 22.59% | 99.93% | 408.79% |
| Change in Net Operating Assets | -92.24% | -20,221.05% | 1,290.31% | -100.83% | -21.63% |
| Cash from Operations | -173.20% | -142.25% | -122.06% | -167.06% | -119.88% |
| Capital Expenditure | -146.15% | -50.00% | -600.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | -146.15% | -50.00% | 99.02% | -- | 99.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.95% | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -100.00% | -- | -- | 97.80% |
| Cash from Financing | -99.94% | -100.03% | -- | -- | 232.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6,869.82% | -116.30% | 40.64% | -189.24% | 97.52% |